1. Home
  2. AFBI vs CRDL Comparison

AFBI vs CRDL Comparison

Compare AFBI & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AFBI

Affinity Bancshares Inc. (MD)

HOLD

Current Price

$22.58

Market Cap

137.0M

Sector

Finance

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.05

Market Cap

132.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFBI
CRDL
Founded
1928
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.0M
132.6M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
AFBI
CRDL
Price
$22.58
$1.05
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
9.5K
325.0K
Earning Date
04-24-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
55.42
N/A
EPS
0.36
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$62.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.35
$0.88
52 Week High
$22.61
$1.71

Technical Indicators

Market Signals
Indicator
AFBI
CRDL
Relative Strength Index (RSI) 62.78 38.76
Support Level $22.43 $0.99
Resistance Level N/A $1.10
Average True Range (ATR) 0.04 0.04
MACD -0.00 0.01
Stochastic Oscillator 81.25 50.00

Price Performance

Historical Comparison
AFBI
CRDL

About AFBI Affinity Bancshares Inc. (MD)

Affinity Bancshares Inc is a bank holding company. The bank provides a range of financial services, including checking and savings accounts, certificates of deposit, mortgage, commercial and consumer loans, and money transfer services, operating across parts of Georgia and offering specialized lending such as dental practice and indirect automobile loans across the Southeastern United States. Its business mainly involves accepting public deposits and investing them in real estate and commercial loans, as well as mortgage-backed securities. The company also gathers deposits nationwide through its virtual bank, FitnessBank, and uses additional funding sources such as Federal Home Loan Bank borrowings.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Share on Social Networks: